Page 1687 - Clinical Small Animal Internal Medicine

Index 1625

p diagnosis 1298–1300 specific pancreatic lipase
VetBooks.ir p53 75–76, 1206–1207 etiology/pathophysiology 1297, pancytopenia 1219
test 603–605, 608
epidemiology 1297, 1299–1300
PAA see pancreatic acinar atrophy
treatment 597–600, 606–608, 607
1299–1300
PAC see plasma aldosterone
concentration gastrinoma 1300 panniculitis 1487
pacemakers glucagonoma 1299–1300 panosteitis 1549
cardiogenic shock 419–420 history and clinical signs 1297, papillary squamous cell
supraventricular arrhythmias 208, 1299–1300 carcinoma 540
210–212, 210 insulinoma 1297–1299 papillomas 1261
pain and pain management prognosis 1298–1300 papillomaviruses (PV) 861–863
approach to the cancer signalment 1297, 1299–1300 clinical signs 862, 862
patient 1203 treatment 1298–1300 diagnosis 862–863
critical care setting 351–352 pancreatic enzyme supplementation epidemiology 861
end‐of‐life care 1555–1556, 586–588 etiology/pathophysiology 861
1558–1559, 1559 pancreatic fecal elastase 586 nonmelanoma skin cancers
feline inflammatory liver pancreatic lipase deficiency 1354, 1357
disease 690 584–586 prevention 863
gallbladder and extrahepatic biliary pancreatic secretory trypsin inhibitor public health implications 863
ducts 723 (PSTI) 591 signalment 862
myelopathy 818 pancreatitis treatment and prognosis 863
oral cavity and salivary glands acute pancreatitis 591–599, papules
537–538, 544 601–602 approach to the dermatologic
pancreatitis 597, 599, 606 biopsy and histology 604 patient 1383
paraneoplastic syndromes 1220 canine 591–600 atopic dermatitis 1404, 1406
pleural effusion 335 characterization in cats 602 miscellaneous skin diseases 1499
rectoanal diseases 613–614 chronic pancreatitis 584, 591–594, paradoxical breathing 335
599–602, 607–608 paralytic ileus 497
shock 406, 410, 410
complications 608 parametric analysis 10, 11, 25
spinal cord injury 745, 745
surgical approaches to thoracic cytology and histology 596–597 paraneoplastic syndromes
disease 326, 328 diagnosis 593–597, 598, 1217–1222
trauma and burns 450–452 602–605 anemia/thrombocytopenia
urethral obstruction 1114 epidemiology 592 1219–1220
venomous snake bites 463–464 etiology/pathophysiology cutaneous manifestations of systemic
palliative care see end‐of‐life care 591–592 disease 1488–1490
palliative radiation therapy (PRT) exocrine pancreatic hypercalcemia 1217–1218
approach to the cancer patient insufficiency 584 hypertrophic osteopathy 1220
1203–1204 feline 601–608 hypoglycemia 1218
bone and joint tumors 1331 history and clinical signs 592–593, myasthenia gravis 1220–1221
nasal tumors 1258 593, 594, 601–602, 602 paraneoplastic alopecia
soft tissue sarcomas 1336 hospitalization 606 1221–1222, 1293, 1433,
palpation imaging 594, 594, 596, 605 1489, 1489
cardiovascular disease 122, 122 interpretation of specialized paraneoplastic exfoliative
pleural effusion 335 tests 604–605 dermatitis 1488–1489
rectoanal diseases 609, 610, 615 motility disorders 572 paraneoplastic pemphigus 1490
trauma and burns 448–449 outpatient management superficial necrolytic
palpebral fissure 737 607–608 dermatitis 1221
pANCA see perinuclear pancreas‐specific biochemistry paraprostatic cysts 1160–1161, 1161
antineutrophilic cytoplasmic 594, 604–605, 608 parasitic infections
antibodies physical examination 601–602 endoscopy 519
pancreatic acinar atrophy (PAA) prognosis 600 feline bronchial asthma 298
584, 608 routine laboratory tests 593, forebrain disorders 783–784
pancreatic elastase (PE‐1) 594 602–603 gallbladder and extrahepatic biliary
pancreatic endocrine speciality diagnostic tests ducts 721, 722, 725
tumors 1297–1301 603–605 gastritis and gastric ulceration 550